These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 22497647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP, Bowers V, Baliga R, Sanders C, LeFor W, Becker D, Thompson D, Resto-Ruiz S, Lopez-Cepero M.
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [Abstract] [Full Text] [Related]

  • 4. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

  • 5. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 6. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 7. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP, Wang CX, Gao W, Fu Q, He XS.
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC.
    Clin Transpl; 2011 Jun; ():1-16. PubMed ID: 22755397
    [Abstract] [Full Text] [Related]

  • 14. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T.
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients.
    Wu P, Everly MJ, Jin J, Mao Y, Chen J.
    Clin Transpl; 2011 Mar; ():365-8. PubMed ID: 22755432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
    Lee HS, Kim MS, Kim YS, Joo DJ, Ju MK, Kim SJ, Kim SI, Huh KH, Park K.
    Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
    [Abstract] [Full Text] [Related]

  • 20. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011 Jan; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.